Depression News

In a new study published in the Journal of Drugs in Dermatology, researchers discussed how and why dermatologists have a significant role to play in the diagnosing and addressing of body dysmorphic disorder.

Risk for psychiatric disorder or suicide attempt is particularly high in the first year following hospitalization for heart disease, and patient support is important to lower such risk, researchers reported.

Is there such a thing as having a broken heart from depression?

More women and providers in both psychiatry and obstetrics and gynecology are becoming aware of the high prevalence of postpartum depression and treatments available, including recently approved zuranolone.

NEW YORK — Paying attention to one’s lifestyle is a cornerstone to maintaining and improving both physical and mental health, according to the new president of the American Psychiatric Association.

Results showed patients with depression who received antidepressants within 6 months prior to total hip or knee arthroplasty had greater improvements in outcomes at 2 years compared with patients with depression who were untreated.

NEW YORK — In this Healio Video Perspective, Reid Robison, MD, MBA, senior principal investigator at Numinus, a company that conducts clinical trials in psychedelics, discusses promising new treatment options for psychiatric conditions.

Johnson & Johnson announced that it has submitted a supplemental new drug application for the approval of esketamine nasal spray as a monotherapy for adults with treatment-resistant depression.

Since the launch of the 988 Suicide & Crisis Lifeline in 2022, counselors have answered more than 10 million calls, texts and chats from people seeking help for suicidal thoughts and mental health crises, according to HHS officials.

Individuals with moderate to less severe treatment-resistant depression may benefit from treatment with ketamine instead of electroconvulsive therapy, according to research from JAMA Network Open.